NEUROD1 and small cell lung carcinoma: Unlike ASCL1-based SCLC tumors, NEUROD1-high tumors exhibit reduced NE expression and display variant morphology expressing lower levels of ENO2 while lacking GRP and DDC expression [10,13,44,53,55].